RecruitingPhase 1NCT06700811
Neurological
Infantile epileptic spasms syndrome
6
studies recruiting now
as of 7 Sept 2026
48
studies registered in total
as of 7 Sept 2026
2
countries with a recruiting site
as of 7 Sept 2026
11 Feb 2025
most recent study posted
among recruiting studies
Recruiting trials
RecruitingPhase 2NCT04289467
Treatment of Refractory Infantile Spasms With Fenfluramine
RecruitingNCT05126914
Multicentre Real-life Follow-up Study of Rare Epileptic Syndromes in Children and Adolescents
RecruitingPhase 2NCT06819670
A Study to Prevent Infantile Spasms Relapse
RecruitingNCT06266234
Characterization by Automated System on Infantile Spasmes
Showing the 5 most recently updated recruiting studies, as recorded 7 Sept 2026. Live status on each study page.
See all 6 recruiting studiesWhere recruiting studies are running
Countries with at least one recruiting site among the studies above, 7 Sept 2026. Tap a country to search trials there.
Keep watching
Get an email when a new Infantile epileptic spasms syndrome study opens.
One email a day at most. Unsubscribe with one click.
Used only for these alerts. Privacy.
Support
Patient organisations
We do not yet list a dedicated organisation for this condition. The directories below are the best route.
About Infantile epileptic spasms syndrome
RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations, and the genes involved (SCN2A, CDKL5, ARX, PIGA, SPTAN1, PLCB1).
Treatments being studied
3 approved treatments and 7 in clinical development, from Open Targets (CC BY 4.0). Not medical advice.
Approved: Ganaxolone (Ztalmy)Approved: Corticotropin (Acth)Approved: Vigabatrin (Kigabeq)
Phase 3Prednisolone (Cortalone)
Phase 3Cannabidiol (Epidiolex)
Phase 3Pyridoxine (Pyridoxine component of vitaped)
Phase 2Radiprodil
Phase 1Cpp-115
Phase 1Blarcamesine Hydrochloride (Anavex)
Phase 1Blarcamesine (Anavex)
Related conditions
Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).